Compare PRG & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRG | TLRY |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | N/A | 2018 |
| Metric | PRG | TLRY |
|---|---|---|
| Price | $29.75 | $11.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $35.00 | ★ $150.00 |
| AVG Volume (30 Days) | 477.8K | ★ 9.5M |
| Earning Date | 10-22-2025 | 01-09-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 10.59 | N/A |
| EPS | ★ 3.96 | N/A |
| Revenue | ★ $2,507,179,000.00 | $830,766,000.00 |
| Revenue This Year | $1.32 | $7.28 |
| Revenue Next Year | $0.64 | $4.51 |
| P/E Ratio | $7.67 | ★ N/A |
| Revenue Growth | ★ 3.71 | 2.31 |
| 52 Week Low | $23.50 | $3.51 |
| 52 Week High | $48.77 | $23.20 |
| Indicator | PRG | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 83.13 |
| Support Level | $28.88 | $7.10 |
| Resistance Level | $31.52 | $8.64 |
| Average True Range (ATR) | 1.02 | 0.74 |
| MACD | 0.22 | 0.76 |
| Stochastic Oscillator | 56.21 | 87.73 |
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.